Technology Transfer

作为一个独立的技术转移办公室，技术转移和创新获取办公室(OTTIA)提供一整套服务，支持国家牙科和颅面研究所S的技术开发活动。为了确保这些活动符合联邦法律、法规和国家卫生研究院的政策，OTTIA的大部分职责包括NIDCR与外部各方(包括大学、制药和生物技术公司)之间的日常交易协议谈判。同时，OTTIA通过促进科学交流、促进NIDCR研究以及获得物质和财政资源来扩大NIDCR内部研究的影响。 协议有助于： *根据材料转让协议交换研究材料； *根据合作研究和发展协议(CRADAS)进行合作研究； *临床研究，以确定在临床CRADAS下的新试剂和设备的安全性和有效性； *根据保密披露和数据共享协议(CDA、DSA)交换机密信息或数据；以及 *为商业评估、产品开发、内部私营部门研究用途发放技术许可证，并支持外部非营利性技术转让努力。 OTTIA审查员工发明报告，评估可专利性，评估商业潜力，并就国内外专利申请的提交做出决定。我们监督NIDCR拥有的发明的专利诉讼和相关法律合同的履行。我们进行营销活动，以授权这些发明，并制定和/或评估发展战略，以实现技术。 OTTIA整合了协议和发明工作，以制定伙伴关系战略，从而补充和扩展NIDCRs的能力，以更好地实现我们的使命目标。 我们的工作人员参加适当的会议、讨论和会议，以随时了解和监测科学家的需求，并向NIH和更广泛的技术转让社区做出贡献和学习。

As a stand alone technology transfer office, the Office of Technology Transfer and Innovation Access (OTTIA) provides a complete array of services, supporting the National Institute of Dental and Craniofacial Research (NIDCR)'s technology development activities. To ensure that these activities comport with Federal statutes, regulations and the policies of the National Institutes of Health, a large part of OTTIA's responsibilities includes the day-to-day negotiations of transactional agreements between the NIDCR and outside parties, including universities, pharmaceutical and biotechnology companies. Concurrently, OTTIA broadens the impact of NIDCR intramural research by fostering scientific exchange, promoting NIDCR research, and obtaining material and financial resources. Agreements facilitate: *exchanges of research materials under the Material Transfer Agreements (MTAs); *collaborative research conducted under cooperative research and development agreements (CRADAs); *clinical studies to determine the safety and efficacy of new agents and devices under clinical CRADAs; *exchanges of confidential information or data under confidential disclosure and data sharing agreements (CDAs, DSAs); and *licensing of technologies for commercial evaluation, product development, internal private-sector research use, and support of external non-profit technology transfer efforts. OTTIA reviews employee invention reports, assesses patentability, evaluates commercial potential, and makes decisions concerning filing of domestic and foreign patent applications. We monitor the patent prosecution, and fulfilment of associated legal contracts, for NIDCR-owned inventions. We conduct marketing activities to license those inventions and develop and/or assess development strategies to bring technologies to fruition. OTTIA integrates the agreement and invention work to develop strategies for partnerships, thus complementing and extending NIDCRs capabilities to better meet our mission goals. Our staff participates in meetings, discussions and conferences, as appropriate, to stay apprised of and monitor scientists' needs, and to both contribute and learn from the NIH and broader Technology Transfer communities.